Search

everythinglearnresearchcommunity

for

Search:↓

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Mice can grow new hair follicles after skin wounds through a process not involving existing hair stem cells, but requiring more research to understand fully.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

People with HIV and low T cell counts have more hair and scalp problems.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

Immune cells affect hair growth and could lead to new hair loss treatments.